Company

Promising results for Pixl

The first study, conducted at Ruhr University Eye Hospital in Germany, evaluated the safety and efficacy of epithelium-off PiXL using Avedro’s KXL II syst on 39 eyes (phakic and pseudophakic) divided into two groups. Results at 12 months donstrated significant improvent with mean uncorrected VA of 20/20 and no loss of best corrected visual acuity (BCVA).{{quote-A:R-W:450-I:2-Q: This technology has huge potential as an addition to our armamentarium for refractive corrections, -WHO:Dr Lim Wee Kiak, co-founder and group Chief Executive Officer of Eagle Eye Centre}}The second study, performed at the Eagle Eye Centre in Singapore, analysed the safety and efficacy of trans-epithelial PiXL in correcting low myopia. Eight patients (14 myopic eyes) who underwent the procedure were followed for nine months post-operatively. Efficacy findings included a mean myopia reduction of 0.75 D; safety evaluations found no significant loss in endothelial cell count or BCVA, and no significant corneal haze post-procedure; and patients reported a high level of patient satisfaction.“This technology has huge potential as an addition to our armamentarium for refractive corrections,” Dr Lim Wee Kiak of the Eagle Eye Centre stated.